Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has shared an update.
Extrawell Pharmaceutical Holdings Limited has announced a special general meeting to be held on March 28, 2025, in Hong Kong. The primary agenda is to appoint SFAI (HK) CPA Limited as the company’s auditor until the next annual general meeting, with the board authorized to set the auditor’s remuneration. This decision could impact the company’s financial transparency and stakeholder confidence.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of pharmaceutical products. The company is primarily engaged in providing healthcare solutions and is positioned in the market to address various medical needs.
YTD Price Performance: -12.00%
Average Trading Volume: 1,323,333
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$105.2M
For detailed information about 0858 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue